HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma glucagon levels suppressed by a glucose load in a man with incidental pancreatic glucagonoma.

AbstractOBJECTIVE:
To describe a patient with a histologically proven pancreatic glucagonoma, noted incidentally during a follow-up visit for high aminotransferase levels, and to evaluate its autonomy with a standard 75-g oral glucose tolerance test.
METHODS:
We present the results of a 2-hour oral glucose tolerance test, with plasma glucagon and blood glucose levels measured every 30 minutes after an oral glucose load. In addition, we provide a brief review of the literature on the diagnosis and management of glucagonomas and the importance of long-term surveillance.
RESULTS:
In our patient, who had a 1-year history of impaired fasting glucose, plasma glucagon levels were persistently suppressed to within the normal range after oral glucose challenge. Octreotide scintigraphy revealed abnormal uptake in the pancreatic tail, and a 2.8-cm mass was removed at laparoscopic distal pancreatectomy. Immunohistochemical staining of the tumor tissue showed intense reactivity for glucagon. Plasma glucagon levels were reduced to <50 pg/mL postoperatively, and scintigraphic study at 4-month follow-up showed no residual uptake at the previous tumor site or elsewhere.
CONCLUSION:
Glucagon-secreting pancreatic tumors are extremely rare. A substantially elevated plasma level of glucagon is usually seen in patients with metastatic tumors. In the early stage of a glucagonoma, however, the plasma glucagon level may be only modestly elevated and may still be susceptible to normal negative feedback inhibition. We demonstrated plasma glucagon complete suppressibility after oral glucose challenge in a patient with a glucagonoma, the first such report in the literature.
AuthorsVinh Q Mai, Ralph C Jones, Judith M Dickert, Patrick W Clyde, K M Mohamed Shakir
JournalEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (Endocr Pract) 2007 Nov-Dec Vol. 13 Issue 7 Pg. 780-4 ISSN: 1934-2403 [Electronic] United States
PMID18194937 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Gastrins
  • Glucagon
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Alanine Transaminase (blood)
  • Aspartate Aminotransferases (blood)
  • Gastrins (analysis)
  • Glucagon (analysis, blood)
  • Glucagonoma (blood, diagnostic imaging, surgery)
  • Glucose Tolerance Test
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Pancreatectomy
  • Pancreatic Neoplasms (blood, diagnostic imaging, surgery)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: